Compare GameStop Corp. (GME) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GameStop Corp. vs Twist Bioscience Corp — how do they compare? GameStop Corp. trades at $26.12 (market cap $12.75B), while Twist Bioscience Corp trades at $159.5 (market cap $10.08B). The key difference: GameStop Corp. is the larger of the two by market cap, and GameStop Corp. is trading nearer its 52-week high, Twist Bioscience Corp nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold GameStop Corp. for 61 Days and Twist Bioscience Corp for 27 Days on average.
| GME | TWST | |
|---|---|---|
Market Cap | $12.75B | $10.08B |
Volume | 13,026,993 | 4,229,037 |
Sector | Consumer Cyclical | Health |
52-Week High | $26.53 | $205.00 |
52-Week Low | $17.87 | $25.45 |
Typical Hold Time | 61 Days | 27 Days |
Enterprise Value | $12.03B | $10.01B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GME trades at $24.58, down 0.73% on the day, with a bullish technical signal from moving averages and strong insider buying. Revenue declined to $3.82B in 2025, but net income improved to $131.3M with a 25.16% net margin. Recent news highlights CEO Ryan Cohen's aggressive share purchases, fueling positive sentiment.
Outlook hinges on execution of the high-margin collectibles pivot and eBay acquisition potential. Risks include revenue volatility and competitive pressures. Analysts are cautious with 55.55% hold ratings, but insider confidence offers a bullish counter-narrative.
TWST trades at $155.65, down 6.78% over 24 hours, with a bearish technical signal and negative cash flows. Revenue growth is strong, reaching $377M in 2025, but the company remains unprofitable with a net income margin of -31.66%. Recent news highlights its role in Eli Lilly's AI-driven drug discovery platform, boosting sentiment despite earnings misses.
The outlook is mixed: analyst consensus is bullish with a $145.20 price target, but high valuation multiples and persistent losses pose risks. Investment opportunity hinges on AI partnerships driving future profitability, while execution risks and cash burn require careful monitoring.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GameStop Corp.
Global Market Group Ltd. operates an Internet website that connects Chinese manufacturers with international buyers. The Company's customers can post company profiles and product information in standardized formats; post product listings; and trade leads.
Read more on GME →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
